Literature DB >> 27225852

MicroRNAs and liver disease.

Motoyuki Otsuka1,2, Takahiro Kishikawa1, Takeshi Yoshikawa1, Mari Yamagami1, Motoko Ohno1, Akemi Takata1, Chikako Shibata1, Rei Ishibashi1, Kazuhiko Koike1.   

Abstract

The biological roles of microRNAs (miRNAs) have been extensively studied. miRNA122 represents more than half of the miRNAs expressed in the liver and has various physiological and pathological functions, which include enhancing hepatitis virus replication, regulating lipid metabolism and suppressing hepatocellular carcinoma. miRNAs, whether globally or individually, have been linked with hepatocarcinogenesis. Furthermore, some miRNAs have been shown to be involved in the pathogenesis of nonalcoholic steatohepatitis. Using nucleotide-based strategies, these miRNAs may be developed as potential therapeutic targets. Because changes in miRNA expression can be measured in sera, they may be used as non-invasive biomarkers if they correctly reflect the pathological state of the liver. In this review, we show the biological roles of representative miRNAs in liver disease and discuss the current issues that remain to be clarified for future clinical applications.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27225852     DOI: 10.1038/jhg.2016.53

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  60 in total

Review 1.  Role of microRNAs in plant and animal development.

Authors:  James C Carrington; Victor Ambros
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

2.  Human RISC couples microRNA biogenesis and posttranscriptional gene silencing.

Authors:  Richard I Gregory; Thimmaiah P Chendrimada; Neil Cooch; Ramin Shiekhattar
Journal:  Cell       Date:  2005-11-03       Impact factor: 41.582

3.  Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling.

Authors:  Guobin He; Debanjan Dhar; Hayato Nakagawa; Joan Font-Burgada; Hisanobu Ogata; Yuhong Jiang; Shabnam Shalapour; Ekihiro Seki; Shawn E Yost; Kristen Jepsen; Kelly A Frazer; Olivier Harismendy; Maria Hatziapostolou; Dimitrios Iliopoulos; Atsushi Suetsugu; Robert M Hoffman; Ryosuke Tateishi; Kazuhiko Koike; Michael Karin
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

Review 4.  The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects.

Authors:  Motoyuki Otsuka; Takahiro Kishikawa; Takeshi Yoshikawa; Motoko Ohno; Akemi Takata; Chikako Shibata; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2013-11-21       Impact factor: 7.527

5.  Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.

Authors:  Shu-Hao Hsu; Bo Wang; Janaiah Kota; Jianhua Yu; Stefan Costinean; Huban Kutay; Lianbo Yu; Shoumei Bai; Krista La Perle; Raghu R Chivukula; Hsiaoyin Mao; Min Wei; K Reed Clark; Jerry R Mendell; Michael A Caligiuri; Samson T Jacob; Joshua T Mendell; Kalpana Ghoshal
Journal:  J Clin Invest       Date:  2012-07-23       Impact factor: 14.808

6.  MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma.

Authors:  Kentaro Kojima; Akemi Takata; Charles Vadnais; Motoyuki Otsuka; Takeshi Yoshikawa; Masao Akanuma; Yuji Kondo; Young Jun Kang; Takahiro Kishikawa; Naoya Kato; Zhifang Xie; Weiping J Zhang; Haruhiko Yoshida; Masao Omata; Alain Nepveu; Kazuhiko Koike
Journal:  Nat Commun       Date:  2011-06-07       Impact factor: 14.919

Review 7.  Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.

Authors:  Yu-Cheng Zhang; Zhuo Xu; Tian-Fu Zhang; Ya-Li Wang
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

8.  The nuclear RNase III Drosha initiates microRNA processing.

Authors:  Yoontae Lee; Chiyoung Ahn; Jinju Han; Hyounjeong Choi; Jaekwang Kim; Jeongbin Yim; Junho Lee; Patrick Provost; Olof Rådmark; Sunyoung Kim; V Narry Kim
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

Review 9.  Current status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinoma.

Authors:  Chikako Shibata; Motoyuki Otsuka; Takahiro Kishikawa; Takeshi Yoshikawa; Motoko Ohno; Akemi Takata; Kazuhiko Koike
Journal:  Mol Cell Ther       Date:  2013-12-13

10.  Selective blockade of microRNA processing by Lin28.

Authors:  Srinivas R Viswanathan; George Q Daley; Richard I Gregory
Journal:  Science       Date:  2008-02-21       Impact factor: 47.728

View more
  24 in total

Review 1.  MicroRNA-based therapeutics in central nervous system injuries.

Authors:  Ping Sun; Da Zhi Liu; Glen C Jickling; Frank R Sharp; Ke-Jie Yin
Journal:  J Cereb Blood Flow Metab       Date:  2018-04-30       Impact factor: 6.200

2.  Plasma circulating microRNAs associated with obesity, body fat distribution, and fat mass: the Rotterdam Study.

Authors:  Xiaofang Zhang; Michelle M J Mens; Yasir J Abozaid; Fariba Ahmadizar; Marlou Limpens; M Arfan Ikram; Fernando Rivadeneira; Trudy Voortman; Maryam Kavousi; Mohsen Ghanbari
Journal:  Int J Obes (Lond)       Date:  2022-10-10       Impact factor: 5.551

3.  Circulating microRNA‑135a‑3p in serum extracellular vesicles as a potential biological marker of non‑alcoholic fatty liver disease.

Authors:  Hemin Jiang; Yu Qian; Ziyang Shen; Yuwei Liu; Yunqiang He; Rui Gao; Min Shen; Shu Chen; Qi Fu; Tao Yang
Journal:  Mol Med Rep       Date:  2021-05-06       Impact factor: 2.952

4.  Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failure.

Authors:  Delia Blaya; Elisa Pose; Mar Coll; Juan José Lozano; Isabel Graupera; Robert Schierwagen; Christian Jansen; Pedro Castro; Sara Fernandez; Julia Sidorova; Mariuca Vasa-Nicotera; Elsa Solà; Joan Caballería; Jonel Trebicka; Pere Ginès; Pau Sancho-Bru
Journal:  JHEP Rep       Date:  2021-01-19

5.  Role of miR-29 in mediating offspring lung phenotype in a rodent model of intrauterine growth restriction.

Authors:  Tsai-Der Chuang; Reiko Sakurai; Ming Gong; Omid Khorram; Virender K Rehan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-08-08       Impact factor: 3.210

Review 6.  The Role of miRNAs in Common Inflammatory Arthropathies: Osteoarthritis and Gouty Arthritis.

Authors:  Panagiota Papanagnou; Theodora Stivarou; Maria Tsironi
Journal:  Biomolecules       Date:  2016-11-11

7.  Induction of miR-96 by Dietary Saturated Fatty Acids Exacerbates Hepatic Insulin Resistance through the Suppression of INSR and IRS-1.

Authors:  Won-Mo Yang; Kyung-Ho Min; Wan Lee
Journal:  PLoS One       Date:  2016-12-30       Impact factor: 3.240

8.  Histone Methyltransferase G9a-Promoted Progression of Hepatocellular Carcinoma Is Targeted by Liver-Specific Hsa-miR-122.

Authors:  Lan-Ting Yuan; Wei-Jiunn Lee; Yi-Chieh Yang; Bo-Rong Chen; Ching-Yao Yang; Min-Wei Chen; Ji-Qing Chen; Michael Hsiao; Ming-Hsien Chien; Kuo-Tai Hua
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

9.  LIX1-like protein promotes liver cancer progression via miR-21-3p-mediated inhibition of fructose-1,6-bisphosphatase.

Authors:  Jie Zou; Xiaoyun Zhu; Dejuan Xiang; Yanqiu Zhang; Jie Li; Zhigui Su; Lingyi Kong; Hao Zhang
Journal:  Acta Pharm Sin B       Date:  2021-02-10       Impact factor: 11.413

10.  mRNA-miRNA-lncRNA Regulatory Network in Nonalcoholic Fatty Liver Disease.

Authors:  Marwa Matboli; Shaimaa H Gadallah; Wafaa M Rashed; Amany Helmy Hasanin; Nada Essawy; Hala M Ghanem; Sanaa Eissa
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.